Introduction {#S0001}
============

The postpartum period is a key time to initiate contraception to prevent unintended, short-interval pregnancies that can lead to maternal and neonatal complications as well as family stressors.[@CIT0001]--[@CIT0003] For this reason, provision of postpartum contraception is recommended by the World Health Organization and the American College of Obstetricians and Gynecologists (among other societies) as a component of quality postpartum care.[@CIT0004],[@CIT0005] However, multiple barriers exist to the patient obtaining postpartum contraception including financial barriers, stress of parenting, systemic racial inequities, physician practice and conscientious refusal, and lack of patient knowledge.[@CIT0006]--[@CIT0011] Whether insurance coverage is one of these external barriers impacting postpartum contraceptive method choice and provision is unclear. Several studies have noted that Medicaid insurance status is associated with increased uptake of postpartum contraception whereas others have pointed to Medicaid insurance as a barrier to accessing highly effective forms of contraception.[@CIT0008],[@CIT0012]--[@CIT0015] Many of these studies were completed prior to passage of the Affordable Care Act and Medicaid expansion which may impact findings given improved contraceptive coverage and thus a presumed reduction in external barriers to access.

Yet, while improved contraceptive coverage due to the Affordable Care Act may have reduced some external barriers to postpartum contraception, it is also ethically and clinically important to understand and uphold the differences in individual patient wishes for future reproduction and pregnancy prevention.[@CIT0016] Even when financial barriers are minimized, contraceptive choice among women will vary based on their individual preferences and these may not be solely based on method effectiveness.[@CIT0017] For example, in one large study in a population with universal healthcare coverage and thus presumed removal of financial barriers to contraceptive preference and access, only 23.4% of women chose and obtained the highly effective methods of either long-acting reversible contraception (LARC) or sterilization with 36.8% declining any form of contraception in the postpartum period.[@CIT0018] Therefore, presuming the ideal postpartum contraceptive method based solely on clinical effectiveness does not fully recognize the autonomous choice of the patient and her reproductive goals.[@CIT0019] Further, women with public versus private insurance have important differences in terms of clinical and demographic factors that are known to impact contraceptive choice such as age, race/ethnicity, parity, and breastfeeding status.[@CIT0020]--[@CIT0023]

Therefore, it is unclear whether prior reported disparities in postpartum contraceptive plan and access based on insurance status remain. Better understanding the factors that impact choice of contraceptive method and barriers to method provision is necessary to provide optimal access to the patient's preferred method of postpartum contraception. The primary objective of this study was to assess differences in method preference and provision of postpartum contraception according to insurance type. We hypothesized that patients with private insurance would be more likely to desire and obtain highly effective methods of contraception such as LARC and sterilization even after accounting for differences in clinical and demographic factors such as age, parity, gestational age, adequacy of prenatal care, route of delivery, race/ethnicity, marital status, and education.

Materials and Methods {#S0002}
=====================

This is a planned secondary analysis of women from a retrospective single-site cohort study involving all (8654) women at our urban, tertiary-care, academic hospital in Cleveland, Ohio who delivered at or beyond 20 weeks of gestation from January 1, 2012, and December 31, 2014. The goal of the primary analysis was to understand differences in postpartum sterilization plan preference and provision for women with public versus private insurance. For this analysis, the cohort was restricted to women who had either private or public (Medicaid, Medicare, or Tricare/Champus) insurance. Those without insurance, who had a previous sterilization, and those with a peripartum mortality were excluded ([Figure 1](#F0001){ref-type="fig"}). Full methodological details have been previously published.[@CIT0024] Briefly, the linked outpatient and inpatient electronic medical record for each subject was reviewed.Figure 1Flow chart of the study population.

We recorded contraceptive method preference at the time of hospital discharge as our primary outcome. All study subjects had a postpartum contraceptive plan documented in the electronic medical record in either the discharge delivery summary or inpatient postpartum daily progress notes. Contraceptive methods were categorized for analysis into four Tiers (Tier 1, Tier 2, Tier 3, and None) based on the Centers for Disease Control and Prevention's Model of Tiered Contraceptive Effectiveness.[@CIT0025] Tier 1 included LARC as well as both female and male sterilization. Tier 2 included injectables, pills, patch, and vaginal ring. Tier 3 included barrier methods, fertility awareness, withdrawal, and abstinence. None included both no method of contraception as well as lactational amenorrhea since it is not considered effective for the full 12 months that was used to define the study outcome of subsequent pregnancy. Fewer than 10% of our patient population is exclusively breastfeeding at time of the outpatient six-week postpartum visit.

The primary outcome of contraceptive method preference by insurance status was compared between Tier 1 and Tier 2 methods to assess preference differences between highly effective methods that were invasive versus moderately effective methods that were non-invasive. We also compared by insurance status between Tier 1/2 and Tier 3/None to understand differences between those preferring high/moderate effectiveness versus lower effectiveness methods that do not require provider involvement. We felt choosing these two comparisons, rather than the six total comparisons if each Tier was compared individually, best represented the contraceptive counseling practices of providers toward a highly- or moderately effective method of contraception. Secondary outcomes included method provision, postpartum visit attendance, and subsequent pregnancy within 365 days of delivery. We defined contraceptive method provision as sterilization completion (either inpatient postpartum or as an interval procedure), LARC placement (interval placement), prescription of a short-acting method (either inpatient prior to discharge or at the outpatient postpartum visit), or patient's report of use of a non-prescription method such as condom. Inpatient postpartum LARC was not available at our hospital (or any other hospital in our region) at the time of this study. Provision was reported as a binary outcome if it occurred within 90 days of delivery. Postpartum visit attendance by 90 days postpartum was recorded. Ninety days were used given our institutional policy to schedule the outpatient postpartum visit at six weeks after delivery, thus allowing additional time for service recovery and the separate scheduling for LARC insertion or sterilization surgery (as was our institution's practice at the time of the study). Finally, the occurrence of subsequent pregnancy within 365 days of delivery was identified from documentation in our electronic medical record. Subsequent pregnancy was defined as either positive urine or serum pregnancy test, presentation for prenatal care, or notation of pregnancy care at an outside hospital in our hospital's clinical documentation.

Insurance status was analyzed as private versus public (Medicaid, Medicare, and Champus/Tricare). The covariates of maternal age at delivery in years, parity at admission, gestational age at delivery in weeks, number of prenatal visits, delivery type, race/ethnicity, marital status, and education level were recorded. Adequate prenatal care was defined as six or more prenatal visits.[@CIT0026] The prespecified demographic and clinical variables listed above were calculated across insurance status using *t*-tests and *χ*^2^ tests for continuous and proportional outcomes, respectively. Two hundred fifty-three (2.9%) for adequate prenatal care, 196 (2.3%) for marital status, and 337 (3.9%) for education level were missing data. The remainder of covariates had no missing data. We had complete data for 7934 (91.7%) of records. For multiple comparisons of tier preference across insurance status, the Holm-Bonferroni correction was used to identify differences in proportions. The outcomes of contraceptive plan preference, provision, postpartum visit attendance, and subsequent pregnancy were analyzed via propensity score analysis. Propensity score matching was used to account for the differences in subject allocation to either public or private insurance providers. All covariates listed above were prespecified for inclusion as potential confounders in contraceptive choice. Propensity score analysis for subsequent pregnancy was calculated both with and without postpartum contraceptive plan provision as an additional covariate given the potential confounding effect. Nearest-neighbors matching was used with a 1:1 ratio of private to public-insured subjects, without replacement. Multiple imputation by chained equations was performed to impute missing data. All tests were two-tailed, and an α of 0.05 was used to define statistical significance.

Analyses for this study were performed using R Version 3.4.0.[@CIT0027] This study was approved by the institutional review board of MetroHealth Medical Center in Cleveland, Ohio. A waiver for written informed consent was granted from our IRB given this research represented de-identified analysis of retrospective data available in the medical record. The study was conducted in accordance with the principles of the Declaration of Helsinki.

Results {#S0003}
=======

Of the 8281 patients in the study cohort, 1372 (16.6%) were privately insured and 6990 (83.4%) were publicly insured ([Table 1](#T0001){ref-type="table"}). Five hundred twenty of 6926 (7.5%) women with public insurance had Medicare insurance, 21 (0.4%) had Champus/Tricare, and the remaining 6385 (92.2%) had Medicaid insurance. There were differences in age, parity, gestational age at delivery, adequacy of prenatal care, route of delivery, race/ethnicity, marital status, and education level across insurance groups. Overall, those with private insurance tended to be older, less parous, of white race, married, and college-educated. Women with private insurance also tended to deliver at a later gestational age, have adequate prenatal care, and deliver via cesarean section.Table 1Clinical/Demographic Differences and Postpartum Contraception Plan Preference Differences Among Women with Private versus Public InsurancePrivate Insurance n=1372Public Insurance n=6909p-valueMean maternal age at delivery (years)28.9 (6.29)25.4 (5.78)\<0.001Parity\<0.001 0678 (49.4)2411 (34.9) 1401 (29.2)1902 (27.5) 2+293 (21.4)2596 (37.6)Mean Gestational age at delivery (weeks)38.4 (2.65)38.1 (2.95)\<0.001Adequate prenatal care1274 (92.8)5453 (78.9)\<0.001Route of Delivery0.005 Spontaneous vaginal930 (67.8)4975 (72.0) Cesarean section388 (28.3)1713 (24.8) Operative vaginal54 (3.9)221 (3.2)Race/Ethnicity\<0.001 Black315 (23.0)3579 (51.8) White847 (61.7)2103 (30.4) Hispanic90 (6.6)874 (12.7) Asian45 (3.3)113 (1.6) Other75 (5.5)240 (3.5)Married756 (55.8)969 (14.4)\<0.001College education994 (72.4)1854 (26.8)\<0.001Postpartum Contraception Plan Tier 1283 (20.6)2025 (29.3)\<0.001 Tier 2444 (32.4)3483 (50.4)\<0.001 Tier 3146 (10.6)221 (3.2)\<0.001 None499 (36.4)1180 (17.1)\<0.001Postpartum Contraception Plan Provision1073 (78.2)5076 (73.5)\<0.001Postpartum Visit Attendance1176 (85.7)4331 (62.7)\<0.001Subsequent Pregnancy293 (21.4)1952 (28.3)\<0.001[^1]

Women with private versus public insurance differed in postpartum contraceptive method preference at the time of discharge when analyzed across Tiers. Privately insured women preferred Tier 1 and Tier 2 methods less often and Tier 3 methods more often than women with public insurance (Tier 1, 20.6% vs 29.3%; Tier 2, 32.4% vs 50.4%; Tier 3, 10.6% vs 3.2%; p \<0.001 for private and public insurances, respectively). Women with private insurance were also more likely to prefer no method of postpartum contraception than women with public insurance (36.4% vs 17.1%, p \<0.001) ([Table 1](#T0001){ref-type="table"}).

The univariable and multivariable outcomes of postpartum contraceptive plan preference, provision, postpartum visit attendance, and subsequent pregnancy within 365 days of delivery after propensity score analysis to adjust for potentially confounding factors are shown in [Table 2](#T0002){ref-type="table"}. There was no difference in frequency of plan for Tier 1 versus Tier 2 postpartum contraception at time of discharge between those with private versus public insurance after adjusting for maternal age, parity, gestational age, adequacy of prenatal care, delivery type, race/ethnicity, marital status, and education level (matched adjusted odds ratio \[maOR\] 0.89, 95% CI 0.69--1.15). Conversely, women with public versus private insurance preferred Tier 1/2 versus Tier 3/No method after controlling for other factors (maOR 1.41, 95% CI 1.17--1.69). There was no difference between insurance types in postpartum contraception plan provision by 90 days after delivery (maOR 0.94, 95% CI 0.75--1.17). However, women with public insurance were less likely to attend their outpatient postpartum visit (maOR 0.54, 95% CI 0.43--0.68) and more likely to have a subsequent pregnancy within 365 days of delivery (maOR 1.29, 95% CI 1.05--1.59) if contraceptive plan provision was not taken into account. Even after accounting for contraceptive plan provision as an additional covariate, there remained a difference in subsequent pregnancy within 365 days of delivery based on insurance status (maOR 1.27, 95% CI 1.03--1.56).Table 2Propensity Score Analysis of Differences in Contraceptive Plan, Provision by 90 Days Postpartum, Postpartum Visit Attendance, and Subsequent Pregnancy Within 365 Days of Delivery by Private versus Public Insurance Status.\*Unmatched Univariable OR (95% CI)Unmatched Multivariable aOR (95% CI)Matched Univariable OR (95% CI)Matched Multivariable maOR (95% CI)Postpartum Contraception Plan -- Tier 1 versus Tier 20.91 (0.77--1.06)0.91 (0.74--1.12)0.85 (0.68--1.07)0.89 (0.69--1.15)Postpartum Contraception Plan -- Tier 1/2 versus Tier 3/None**3.34 (2.99--3.73)1.43 (1.24--1.66)1.40 (1.19--1.65)1.41 (1.17--1.69)**Postpartum Contraception Plan Provision0.88 (0.76--1.02)1.01 (0.83--1.22)0.95 (0.78--1.17)0.94 (0.75--1.17)Postpartum visit attendance**0.28 (0.24--0.33)0.55 (0.45--0.67)0.52 (0.42--0.64)0.54 (0.43--0.68)**Subsequent Pregnancy (without provision as a covariate)**1.45 (1.26--1.67)**1.13 (0.96--1.35)**1.33 (1.09--1.63)1.29 (1.05--1.59)**Subsequent Pregnancy (including provision as a covariate)**1.45 (1.26--1.67)**1.13 (0.96--1.34)**1.25 (1.02--1.54)1.27 (1.03--1.56)**[^2]

Discussion {#S0004}
==========

There are significant differences in the population of patients insured by private versus public insurance at our hospital in terms of clinical and demographic factors. Many of these factors are associated with contraceptive preference, access to care, and unintended pregnancy rates.[@CIT0017],[@CIT0021],[@CIT0028]--[@CIT0030] After adjusting for these relevant factors (maternal age, parity, gestational age, adequacy of prenatal care, delivery type, race/ethnicity, marital status, and education level), private versus public insurance status was not associated with a difference in plan for highly effective (Tier 1) versus moderately effective (Tier 2) method for postpartum contraception or plan provision within 90 days of delivery, contrary to our initial hypothesis.

Women with public compared with private insurance were more likely to choose a highly- or moderately effective versus Tier 3/No method for postpartum contraception. It is unclear whether this difference is due to patient-mediated or physician-level factors prompting differences in contraceptive plan preference. Patient-mediated factors include potential differences in future pregnancy intention between the two groups. However, women choose contraceptive methods based on multiple factors in addition to simply effectiveness; therefore, future pregnancy intention and choice of postpartum contraception method are not always linked.[@CIT0017],[@CIT0031] Physician-level factors may include potential implicit bias in counseling based on clinical, demographic, and insurance-based differences as well as practice pattern differences between individual providers.[@CIT0032]--[@CIT0034] Regardless of the reason for these differences in preference, barriers to the provision of the desired contraceptive plan should be minimized.

Public insurance status was associated with decreased rates of postpartum visit attendance and increased rates of subsequent pregnancy within 365 days of delivery in our study, similar to the published literature.[@CIT0035]--[@CIT0037] Known racial/ethnic variation in rates of contraceptive failure, adherence, discontinuation, and pregnancy planning and intendedness may have impacted our findings.[@CIT0038]--[@CIT0043] Therefore, ideally, women desiring highly- or moderately effective methods of contraception should have these methods provided prior to hospital discharge. However, carefully nuanced contraceptive counseling is needed to ensure that patients receive accurate medical counseling regarding the risks of short-interval pregnancy without the assumption that patients themselves will similarly devalue short-interval pregnancy in terms of their own reproductive planning.

Our study is limited by its retrospective nature and potential loss to follow up. Women who did not return for postpartum visits may have received care elsewhere or outside of the 90-day window we considered for the outcome of provision. Future pregnancy intention was not measured which may impact the choice of postpartum contraceptive method. Additionally, as a single-center study, contraceptive practices and barriers related to our institution's policies, practices, patient characteristics may limit generalizability of our results. For example, during the study timeframe, we did not generally perform same-day LARC insertion at time of the postpartum visit. As a county hospital that serves primarily the underserved, most of our patients remain Medicaid-eligible after the pregnancy-related coverage expires. Bearing in mind that this study is a secondary analysis, observational in nature, and odds ratios for outcomes are within the zone of potential bias, results should be interpreted with caution.

Implications for Practice and/or Policy {#S0005}
=======================================

Better understanding patient decision-making regarding postpartum contraception is imperative to reducing external barriers to care and eradicating disparities in contraceptive and reproductive health outcomes. Prospective, longitudinal assessment of pregnancy intention, contraceptive goals, factors considered in method choice, sources of information, effect of insurance coverage, role of physician counseling, and impact of the social and medical environment on contraceptive decision-making is necessary.

Conclusions {#S0006}
===========

In conclusion, after accounting for confounding clinical and demographic factors, public insurance does not serve as a barrier to effective postpartum contraceptive method preference or provision. Women with public insurance were more likely to plan on either a highly or moderately effective method of postpartum contraception at time of hospital discharge than those with private insurance. Strategies to individualize contraceptive counseling and planning surrounding future pregnancies are necessary.
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[^1]: **Notes:** Presented as n (%) or mean (SD). Tier 1 -- long-acting reversible contraception, female sterilization, male sterilization. Tier 2 -- injectables, pills, patch, vaginal ring. Tier 3 -- barrier methods, fertility awareness, withdrawal, abstinence. None -- no method, lactational amenorrhea.

[^2]: **Notes:** \*Insurance status was recorded as private versus public (Medicaid, Medicare, or Champus/Tricare). Other covariates included maternal age at delivery in years, parity at admission, gestational age at delivery in weeks, adequacy of prenatal care, delivery type, race/ethnicity, marital status, and education level. Bold values indicate significant associations.

    **Abbreviations:** OR, odds ratio; aOR, adjusted odds ratio; maOR, matched adjusted odds ratio; 95% CI, 95% Confidence Interval.
